Bharat Biotech: Authorized in India. Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization ...
News
- A look at COVID-19 vaccines already in use, or getting close
- Initial public offerings scheduled to debut next week
Evaxion Biotech - Copenhagen, Denmark, 2.8 million shares, priced $10-$12, managed by Oppenheimer & Co/Ladenburg Thalmann. Proposed ...
- As scientists turn their attention to COVID-19, other research is not getting done - and that can have ...
In biomedicine, academic labs study a specific topic and are led by experienced scientists who direct trainees. Over several years of training, a select ...
- Chevron, Johnson & Johnson fall; Novavax, Skyworks rise
The biotechnology company released encouraging results for a potential COVID-19 vaccine. Robert Half International Inc., up $2.70 to $67.50.
- D-Law, Charlotte Jones Send "Heroes" To Super Bowl
Dr. Clifton Molak, from San Antonio, began his medical journey at Texas A&M University graduating with a degree in biomedical engineering.